Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AZD2962 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on AZD2962, a putative IRAK4 inhibitor (Jul 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AZD2962 | AZD-2962|AZD 2962 | IRAK4 Inhibitor 8 | Limited information is currently available on AZD2962, a putative IRAK4 inhibitor (Jul 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07064122 | Phase Ib/II | AZD2962 | A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers) | Recruiting | USA | GBR | ESP | AUS | 3 |